Abstract

Microsatellite and KRAS status affect the development of colorectal carcinoma (CRC) and can warrant specific clinical management. This study assesses current trends and outcomes of testing for microsatellite and KRAS status in stage IV CRC patients in the US.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call